Shares of Threshold Pharmaceuticals (THLD) gain 5.5% in premarket trading after Lazard Capital...

|About: Threshold Pharmaceuticals... (THLD)|By:, SA News Editor

Shares of Threshold Pharmaceuticals (THLD) gain 5.5% in premarket trading after Lazard Capital lifts its price target to a high-flying $15 after digesting the firm's good results from a trial of its pancreatic cancer drug candidate.